Lee Chae, the Chief Executive Officer of Magnachip Semiconductor Corp, has recently increased his stake in the company through several stock purchases. This move, which raises his total ownership to 548,750 shares, demonstrates his confidence in the future of Magnachip, a player in the semiconductor industry.
On November 16, 2026, Chae reported multiple transactions involving the purchase of common stock. The filings indicate that he acquired 10,000 shares at a price of $2.3285, followed by additional purchases of 10,000 shares at $2.3394, and 20,000 shares at $2.3368. These transactions were part of a series of purchases made on November 13 and 16, totaling over 100,000 shares acquired at various prices.
Magnachip Semiconductor Corp, identified by CIK 0001325702, is incorporated in Delaware and operates primarily in the semiconductor industry. The company has undergone several name changes, with its most recent being in 2011. It is classified under the Standard Industrial Classification (SIC) for semiconductors and related devices.
The SEC filing, with accession number 0001193125-26-464325, details Chae's transactions and reflects his ongoing commitment to the company. Following these transactions, he now owns 548,750 shares directly, showcasing a significant investment in his own firm.
This increase in ownership could have implications for both the company and the broader semiconductor industry. As executives like Chae invest in their companies, it may signal to investors and stakeholders that they are confident in the future performance and growth of the business. This trend could influence other leaders in the semiconductor sector, prompting them to consider similar actions to bolster investor confidence.
Moving forward, it remains to be seen how these stock purchases will impact Magnachip's market position and if other executives will follow suit in light of industry challenges. The filing does not specify any upcoming events or additional filings related to these transactions.
Read Next
Jamie Odell Reports Major Stock Transactions with Light & Wonder
Guiheen Lawrence P. Acquires 10,000 Shares of ADMA Biologics
Gilliam Joseph E reports significant stock transactions
ADMA Biologics CEO Grossman Reports Major Stock Transactions
Saba Capital Management reveals stock acquisitions in SEC filing
Evans Bronwyn Reports Multiple Stock Transactions









